Please login to the form below
Diabetes UK
This page shows the latest Diabetes UK news and features for those working in and with pharma, biotech and healthcare.
University of Birmingham to launch type 1 diabetes trial for at-risk children
If type 1 diabetes is undiagnosed or untreated, it can cause life-threatening issues. ... many nationwide, given that approximately 29, 000 children in the UK currently have type 1 diabetes, out of a total of around 400, 000 people.
Latest news
-
QiC Diabetes awards 2022 celebrate UK healthcare excellence
Recognising outstanding and innovative contributions in the field of diabetes, entries were submitted from across the UK demonstrating creativity and compassion in medical excellence and care. ... Presenting the first award of the night, Simon O’Neill,
-
Novo Nordisk’s insulin icodec shows promise as once-weekly type 2 diabetes treatment
More than 4.9 million people in the UK have diabetes, around 90% of which have type 2 diabetes, according to Diabetes UK. ... There is currently no cure for type 2 diabetes, with available treatment options focused on disease management, including diet
-
Dexcom launches next-generation continuous glucose monitor for diabetes patients
Dexcom has announced the launch of its next-generation continuous glucose monitor (CGM) – Dexcom G7 – for people with diabetes aged two years and older in the UK, Ireland, Germany, Austria and ... More than 4.9 million people in the UK have diabetes,
-
Novo Nordisk’s insulin icodec shows promise as once-weekly type 2 diabetes treatment
the company at the European Association for the Study of Diabetes (EASD) annual meeting. ... More than 4.9 million people in the UK have diabetes, around 90% of which have type 2 diabetes, according to Diabetes UK.
-
Novo Nordisk announces positive phase 2 trial results for type 2 diabetes treatment
More than 4.9 million people in the UK have diabetes, around 90% of which have type 2 diabetes. ... More than 4.9 million people in the UK have diabetes, around 90% of which have type 2 diabetes, according to Diabetes UK.
More from news
Approximately 7 fully matching, plus 126 partially matching documents found.
Latest Intelligence
-
Patient diversity in clinical trials needs to be centre stage
It’s not; it’s a health equality issue. There is need for more education and awareness.” The Demand Diversity Report, which has focused on UK and US markets, calls for ... UK diabetes trials which showed a 5.5% South Asian participation rate
-
Understand, identify and partner with HCPs to improve patient support
Groups such as the Diabetes Advocacy Alliance work to raise awareness among policymakers and legislators in the United States, while others, such as Diabetes.co.uk, provide a Europe-wide community ... Diabetes UK, as mentioned previously, which has a
-
Could formulary intelligence be your brand differentiator?
Five years ago, we tracked the Y1 formulary adoption of five high-profile UK product launches in respiratory and diabetes. ... Abasaglar – a biosimilar to Lantus (diabetes), offering a money-saving value proposition for medicines management.
-
Quality in Care Diabetes 2018: the best in innovative diabetes care
Now in its eighth year, QiC Diabetes rewards initiatives undertaken in the UK and Ireland to improve outcomes and quality of life for people living with diabetes – spanning people with type ... As one of the first diabetes UK clinical champions, Dr
-
Mylan sees the UK paving the way for an insulin game changer
The fertile UK landscape is an alluring springboard for biosimilars, with Mylan recording strong uptakes in previous launches. ... biosimilars. “The UK can take the lead on showing other countries how to properly manage the opportunity of
More from intelligence
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest appointments
-
Hanover Health appoints James Mole as a director
With fifteen years’ experience of working with government, parliament and healthcare charities – including Cancer Research UK, Diabetes UK and the Alzheimer's Society – Butterworth has a proven track record in senior
-
Ashfield, Health Unlimited and Ashley Communications add to their teams
Pierre Van Weperen (pictured above) has joined Ashfield as its commercial and patient solutions managing director for the UK. ... Van Weperen was most recently at diabetes giant Novo Nordisk, where he worked on delivering insulin and GLP1 biosimilar
-
Janssen's Matthew Kirby takes up senior role at Wilmington Healthcare
Kirby sent seven years at the pharma firm, most recently serving as regional business manager in the UK for its diabetes sales team across the south east.
-
Hayward Medical Communications adds to its team
Thomas joins the Newmarket, UK-based agency as its new business director and he arrives from Aegate, a company that focuses on the digital authentication of medicines. ... Prior to that his roles included working as an NHS commercial director and a spell
-
Portland Health adds to staff as business grows
With experience in a wide range of therapeutic areas, she has advised the likes of Abbott UK, MSD, Novartis Oncology UK, Pfizer UK, Sanofi Diabetes and Johnson &Johnson. ... Flint has established extensive patient advocacy partnerships across a number of
More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.
Latest from PMHub
-
Diabetes management – should there be a 'one-size fit all' approach?
Diabetes UK produces a range of straight-forward resources which are a great help for these individuals, including the Food Labels Made Easy Guide which can be printed off either by ... Diabetes UK provide a range of simplified guides for diabetes
-
Onyx Health Tackles Type 2 Diabetes with Diabetes Lifestyle Doctors
Diabetes Lifestyle Doctors is the UK's first independent doctor-led interactive service and is designed to reduce the potentially devastating effects of type 2 diabetes. ... There are currently 3.4 million people with type 2 diabetes in the UK, which is
-
WHITE PAPER: What's missing in women's health?
Us, Diabetes and a Lot of Facts and Stats. Diabetes UK. ... 2019. https://www. diabetes.org.uk/resources-s3/2019-02/1362B_Facts% 20and% 20stats% 20 Update% 20Jan% 202019_LOW% 20RES_EXTERNAL.pdf. Accessed May 4,.
-
Should diversity in clinical trials be mandatory?
A review of 12 diabetes trials found that t he mean South Asian involvement was 5.5%, despite South Asians representing 11.2% of the UK population and disproportionally suffering from ... diabetes. Also only 4 of the 12 studies did not report ethnicity
-
OLED Medical Technology Saving Patient’s Sight During COVID-19 Pandemic
Diabetic Retinopathy is a complication of diabetes caused by high blood sugar levels damaging the back of the eye, which can cause blindness if left untreated. ... The treatment reduces and reverses the effects of Diabetic Retinopathy. In the UK,
More from PMHub
Approximately 0 fully matching, plus 17 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- Europe’s cancer community publishes new report on transforming patient care
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- EU to revise pharmaceuticals law amid antibiotic shortages
- European MPs call for urgent action against antimicrobial resistance
- The role of medical communications in building credibility for healthtech
PMHub
Kardex
Kardex is a global industry partner for intralogistics solutions and a leading supplier of automated storage solutions and material handling...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
